NASDAQ · OMDA
Omada Health, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for OMDA: Nov 05, 2026
Omada Health, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $0.01. The reported EPS for the same quarter last year was $-0.03.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.01 | $0.03 | $0.00 | 2 |
| Dec 2026 | $0.03 | $0.03 | $0.02 | 2 |
| Mar 2027 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Jun 2027 | $0.07 | $0.07 | $0.07 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · Zacks · MarketBeat · BNK Invest- The Motley Fool · Sep 23, 8:50 AM EDTOmada Health President Wei-Li Shao Sells 9,418 Shares for $236,000The transaction represented 3% of the insider's direct equity holdings before the filing.
- The Motley Fool · Sep 9, 5:15 AM EDTInsider Alert: Omada Health CEO Sean Duffy Sells 31,457 SharesTraded 31,457 shares with a transaction value of ~$735,150 based on a weighted average price of $23.37 per share.
- Zacks · Sep 7, 10:51 AM EDTHere's Why Teladoc's Integrated Care Business Deserves More AttentionTDOC's Integrated Care is driving profitability as chronic care gains traction, potentially making it the company's key earnings driver.
- The Motley Fool · Aug 13, 6:32 PM EDTOmada Health (OMDA) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 12, 1:03 PM EDTIs Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.
- Zacks · Aug 12, 12:57 PM EDTHinge Health's Cylinder Deal Opens a $135B GI Care Growth OpportunityHNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.
- Zacks · Aug 12, 12:53 PM EDTHNGE Rallies 64.6% in 3 Months as Growth and Margins Gain MomentumHinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.
- MarketBeat · Aug 11, 9:04 AM EDTOmada Health Touts Record Q2 as GLP-1 Demand Fuels Growth StrategyOmada Health (NASDAQ:OMDA) highlighted record second-quarter revenue and margin performance at the Canaccord Genuity Growth Conference, while outlining its strategy to expand across cardiometabolic conditions, deepen channel partnerships and use GLP-1-related demand to broaden cu
- Zacks · Aug 7, 7:00 PM EDTOmada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesAlthough the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- MarketBeat · Aug 7, 3:04 AM EDTOmada Health Q2 Earnings Call HighlightsOmada Health (NASDAQ:OMDA) reported record second-quarter results for 2026, citing broad-based growth across its cardiometabolic programs, expanding channel partnerships and lower costs to serve members. The company also announced that President Wei-Li Shao will succeed Co-founde
- Zacks · Aug 6, 5:40 PM EDTOmada Health, Inc. (OMDA) Q2 Earnings and Revenues Top EstimatesOmada Health, Inc. (OMDA) delivered earnings and revenue surprises of +200.00% and +8.53%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- BNK Invest · Jul 14, 8:34 AM EDTOmada Health Reaches Analyst Target PriceIn recent trading, shares of Omada Health Inc (Symbol: OMDA) have crossed above the average analyst 12-month target price of $23.33, changing hands for $23.50/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Omada Health, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.